Tyra Biosciences Inc Sustainability Reports
Tyra Biosciences, Inc. is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for cancer patients. The company utilizes its proprietary SNÅP platform to design selective small molecule inhibitors targeting genetic alterations.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00RCQD9F9
2 reports from 2023 to 2024